John Pawlak
Director/Board Member at Huntington's Disease Society of America
Network origin in John Pawlak first degree
Entity | Entity type | Industry | |
---|---|---|---|
Huntington's Disease Society of America
5
| Non-Profit Organization | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John Pawlak via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
IMMUNOGEN, INC. | Biotechnology | Corporate Officer/Principal | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | General Counsel | |
University of West Georgia | College/University | Undergraduate Degree | |
San Diego State University | College/University | Undergraduate Degree | |
Kean University | College/University | Undergraduate Degree | |
University of Massachusetts | College/University | Undergraduate Degree | |
Chargers Football Co. LLC
Chargers Football Co. LLC Movies/EntertainmentConsumer Services The Chargers Football Co. LLC owns and operates a football team. It focuses on football operations, scouting, stadium and game operations, brand development, broadcasting and marketing partnerships. The firm also engages in youth football and junior training camp activities. The company was founded in August 1959 and is headquartered in San Diego, CA. | Movies/Entertainment | Public Communications Contact | |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Corporate Officer/Principal | |
EDITAS MEDICINE, INC. | Biotechnology | Corporate Officer/Principal | |
University of Virginia Darden School of Business | College/University | Masters Business Admin | |
Temple University School of Pharmacy | College/University | Graduate Degree | |
FIBROBIOLOGICS, INC. | Biotechnology | Director/Board Member | |
Rare-X
Rare-X Packaged SoftwareTechnology Services Part of Global Genes, Rare-X is a patient advocacy organization based in Washington. Rare-X is focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by a rare disease. Rare-X is building the largest collaborative patient-driven, open-data access project for rare diseases ly, gathering structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data sharing technology. Rare-X's goal is to build the largest collaborative patient-driven, open-data access project for rare diseases ly. The American company was founded in 2019 by Nicole Boice. The CEO is Charlene Son Rigby. Rare-X was acquired by Global Genes on February 07, 2023. | Packaged Software | Director/Board Member |
Statistics
International
United States | 16 |
Denmark | 2 |
Sectoral
Consumer Services | 8 |
Health Technology | 6 |
Commercial Services | 3 |
Health Services | 2 |
Technology Services | 2 |
Operational
Director/Board Member | 6 |
Corporate Officer/Principal | 6 |
Undergraduate Degree | 4 |
Public Communications Contact | 1 |
Chief Operating Officer | 1 |
Most connected contacts
Insiders | |
---|---|
Stacy Coen | 9 |
Michelle McGuinness | 4 |
Bill Johnston | 3 |
William Monie | 3 |
Wendy Erler | 2 |
- Stock Market
- Insiders
- John Pawlak
- Company connections